CD13 |
|
|
|
Aminopeptidase N, CMV receptor (Arienti et al. 1997a; Kasman 2005) |
Band 1 |
36 |
2485 |
41.23 |
Band 2 |
14 |
956 |
16.69 |
Band 3 |
9 |
791 |
10.10 |
|
CD26 |
|
|
|
Dipeptidyl peptidase IV, T cell activation (Burden et al. 2006; Yu et al. 2010) |
Band 1 |
19 |
961 |
13.61 |
Band2 |
22 |
1008 |
29.44 |
|
Neprilysin |
|
|
|
Membrane metalloendopeptidase, Amyloid β regulation (Hersh and Rodgers 2008) |
Band 2 |
25 |
1086 |
9.83 |
Band 3 |
36 |
1720 |
43.20 |
|
Prostatic Acid Phosphatase |
|
|
|
Semen Liquefaction, Enhanced HIV infectivity (Hassan et al. 2010; Kim et al. 2010) |
Band 4 |
24 |
824 |
31.35 |
Band 5 |
24 |
584 |
26.61 |
|
Zinc α2-glycoprotien |
|
|
|
Stimulation of lipolysis, Sperm motility (Hassen et al. 2008) |
Band 4 |
40 |
674 |
12.77 |
Band 5 |
35 |
688 |
28.17 |
Band 6 |
61 |
1428 |
60.64 |
|
Alpha-1-acid glycoprotein |
|
|
|
Immunosuppression (Lee et al. 2010) |
Band 5 |
15 |
241 |
11.41 |
|
PSA |
|
|
|
Semen liquefaction, Prostate cancer (Williams et al. 2007; Jones et al. 2010) |
Band 7 |
31 |
470 |
36.45 |
|
Clusterin |
|
|
|
Apoptosis (Li et al. 2010) |
Band 7 |
23 |
671 |
13.11 |
|
Galectin-3 |
|
|
|
Cell adhesion, Immunomodulation, Cancer progression (Dumic et al. 2006) |
Band 8 |
41 |
784 |
69.76 |
Band 9 |
41 |
702 |
71.72 |
Band 10 |
41 |
655 |
57.10 |
Band 11 |
41 |
790 |
73.30 |
Band 12 |
35 |
512 |
45.66 |
|
Antibacterial Protein |
|
|
|
Antibacterial peptide (Zu et al. 2003) |
Band 12 |
33 |
308 |
41.10 |